Focus Stocks
Bristol-Myers Squibb to Present at Leerink Swann 2012 Global Healthcare Conference
Published on Wednesday, 08 February 2012 15:22 Written by TradersHuddle Staff
NEW YORK-( Business Wire )-Bristol-Myers Squibb Company (NYSE: BMY) will present at the Leerink Swann 2012 Global Healthcare Conference Wednesday, February 15, 2012, in New York. Beatrice Cazala, executive vice president, Commercial Operations will make a formal presentation about the company at 11:30 a.m. EST.
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Related Articles
- Bristol-Myers Squibb to Take Part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference
- New Analyst Coverage: ACOR, BMY, CODE, MU, SNDK
- New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting
- U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)
- Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
- Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
- Biotech Takeovers: Who’s Next On The Block?
- Bristol-Myers Squibb to Present at Deutsche Bank Health Care Conference
- Bristol-Myers Squibb Invites Public to Listen to Webcast of 2012 Annual Meeting
- Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
Related Partner Headlines
- Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner - TheStreet.com
- Celldex Targeted Drug Shrinks Breast Cancer - TheStreet.com
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Loser - TheStreet.com
- U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility - Benzinga
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Loser - TheStreet.com
- Cramer's 'Mad Money' Recap: Timing Is Everything (Final) - TheStreet.com
- UPDATE: Bristol-Myers Posts Rise In Q1 Profit - Benzinga
- Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner - TheStreet.com
- Vertex Hopes Two Cystic Fibrosis Drugs Better than One - TheStreet.com
- Gilead, Bristol Put Profits Ahead of Best Care for Hep C Patients - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012 -
Diamond Value Management strategy and corporate turnaround leverages Rockwell repositioning









